In Alzheimer disease, therapies to improve the core symptoms and perhaps even slow disease progression include cholinesterase inhibitors, receptor agonists, antiinflammatory drugs, and antioxidants. Neuroleptics, antiepileptics, and nondrug approaches are used to control and relieve complications such as delusions, hallucinations, paranoia, and agitated behavior. We outline a practical approach to the use of these therapies.
机构:
NEW YORK STATE PSYCHIAT INST & HOSP,MEMORY DISORDERS CTR,NEW YORK,NY 10032NEW YORK STATE PSYCHIAT INST & HOSP,MEMORY DISORDERS CTR,NEW YORK,NY 10032
机构:
Dipartimento di Patologia Sperimentale, Università di Bologna, 40126 BolognaDipartimento di Patologia Sperimentale, Università di Bologna, 40126 Bologna
Licastro F.
Caruso C.
论文数: 0引用数: 0
h-index: 0
机构:
Gruppo di Studio sull'Immunosenescenza, Dipartimento di Biopatologia e Metodologie Biomediche, Università di Palermo, 90134 PalermoDipartimento di Patologia Sperimentale, Università di Bologna, 40126 Bologna
机构:
South Australian Hlth & Med Res Inst SAHMRI, Hopwood Ctr Neurobiol, Lysosomal Hlth Ageing, Lifelong Hlth Theme, Adelaide, AustraliaSouth Australian Hlth & Med Res Inst SAHMRI, Hopwood Ctr Neurobiol, Lysosomal Hlth Ageing, Lifelong Hlth Theme, Adelaide, Australia
Carosi, Julian M.
Sargeant, Timothy J.
论文数: 0引用数: 0
h-index: 0
机构:
South Australian Hlth & Med Res Inst SAHMRI, Hopwood Ctr Neurobiol, Lysosomal Hlth Ageing, Lifelong Hlth Theme, Adelaide, AustraliaSouth Australian Hlth & Med Res Inst SAHMRI, Hopwood Ctr Neurobiol, Lysosomal Hlth Ageing, Lifelong Hlth Theme, Adelaide, Australia
机构:
Xavier Univ Louisiana, Coll Pharm, Div Basic Pharmaceut Sci, New Orleans, LA 70125 USAXavier Univ Louisiana, Coll Pharm, Div Basic Pharmaceut Sci, New Orleans, LA 70125 USA